Anti-BCMA CAR T-cells in myeloma: what data do we have so far? - 101793

Spotlight
Video

Anti-BCMA CAR T-cells in myeloma: what data do we have so far?

VJHemOnc has 1608 videos Subscribe Here

Loading........
Description: BCMA is an exciting therapeutic target for multiple myeloma (MM). Here, Yi Lin, MD, PhD, of the Mayo Clinic, Rochester, MN, discusses current trials of CAR T-cell products that are targeting BCMA, and their data so far. She highlights that the patient population who have received this therapy so far have been heavily pre-treated and have limited therapeutic options. Dr Lin also discusses future strategies to futher improve CAR T-cell therapy. This interview took place at the Myeloma 2018 meeting, held in San Diego, CA.
Shared By : VJHemOnc
Posted on : 09/14/18
Added : 1 month ago
Category : Multiple Myeloma